Japan’s VC-backed Oncolys Pharma raises $64m in Tokyo IPO
Oncolys Pharma, a VC-backed developer of drugs targeting cancer and serious infectious diseases, saw its stock open at JPY3,500 per share - a 34.6% premium on the offering price - on its first day of trading in Tokyo. This followed a JPY6.6 billion ($64.4 million) IPO.
The price peaked at JPY3,750 before eventually closing at JPY3,530 on Friday. The firm - which listed on the Mothers (market of the high-growth and emerging stocks) section of the Tokyo Stock Exchange...
More on Healthcare
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.